u buyer steps in at 1.96 If this Friday, GSK agrees to settle the $300-400m claim by BTA out of court, what value would this ascribe to the sp?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%